US Medicare spending on prescription drugs sold through retail settings rose 5.9% in 2018, following growth of 4.4% the year before, according to the annual National Health Expenditures Report released by the Centers for Medicare and Medicaid Services 5 on December.
The acceleration was driven by faster growth in drug spending by Medicare Advantage plans, CMS actuaries said during a press...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?